Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-31 1:12 pm Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 11,867,780 10.000% | -99,685 (-0.83%) | Filing History |
| 2023-01-23 12:34 pm Purchase | 2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 6,753,629 5.600% | 499,420 (+7.99%) | Filing History |
| 2023-01-10 07:39 am Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 2,586,932 2.180% | -10,336,437 (-79.98%) | Filing History |
| 2022-08-19 4:03 pm Purchase | 2022-08-09 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 12,232,267 9.990% | 12,232,267 (New Position) | Filing History |
| 2022-04-11 2:02 pm Purchase | 2022-03-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 12,923,369 12.650% | 5,230,958 (+68.00%) | Filing History |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | BAKER BROS. ADVISORS LP | 8,131,678 8.000% | 66,846 (+0.83%) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | TANG CAPITAL PARTNERS LP | 7,783,688 7.600% | 144,588 (+1.89%) | Filing History |
| 2022-02-14 2:15 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 6,405,865 6.280% | 1,044,254 (+19.48%) | Filing History |
| 2022-02-14 11:17 am Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | UBS OCONNOR LLC | 8,275,000 8.120% | 8,275,000 (New Position) | Filing History |
| 2022-02-11 09:52 am Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 7,692,411 7.550% | 7,692,411 (New Position) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | The Vanguard Group | 9,609,045 9.430% | 1,297,277 (+15.61%) | Filing History |
| 2022-02-04 09:27 am Sale | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | WELLINGTON MANAGEMENT CO LLP | 1,638,273 1.610% | -5,297,641 (-76.38%) | Filing History |
| 2022-02-03 3:01 pm Sale | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 11,967,465 11.700% | -721,237 (-5.68%) | Filing History |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | BlackRock Inc. BLK | 7,682,201 7.500% | 795,269 (+11.55%) | Filing History |
| 2022-01-24 12:02 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 6,254,209 6.100% | 6,254,209 (New Position) | Filing History |
| 2021-02-16 5:09 pm Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | BAKER BROS. ADVISORS LP | 8,064,832 8.700% | 84,979 (+1.06%) | Filing History |
| 2021-02-16 4:15 pm Sale | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | TANG CAPITAL PARTNERS LP | 7,639,100 7.800% | -2,110,244 (-21.64%) | Filing History |
| 2021-02-16 1:29 pm Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 5,361,611 5.900% | 5,361,611 (New Position) | Filing History |
| 2021-02-11 1:43 pm Sale | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -4,915,313 (Position Closed) | Filing History |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | The Vanguard Group | 8,311,768 9.150% | 455,202 (+5.79%) | Filing History |